Rallybio Statistics
NASDAQ: RLYBHealthcareBiotechnologyUSD
16.99+0.06 (+0.35%)
At close: Oct 8, 4:00 PM ET · Delayed 15 min
Rallybio by the numbers
Rallybio has a market capitalization of $90.3 million based on 5.31M shares outstanding. Its trailing P/E ratio is 2.1. The stock trades 1.4% above its 50-day average and 40.7% above its 200-day average.
Average daily trading volume is 21.33K shares, or about $362,329 in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
RLYB valuation vs. peer median
| Metric | RLYB | Peer median | Difference |
|---|---|---|---|
| Market cap | $90.26M | $89.40M | +1% |
| Avg. volume | 21.33K | 387.75K | -95% |
Peer median across 8 companies: NMRA, MIST, ICCC, EQ, ATRA, OKUR, CGTX, NRXS.
Valuation
- Market cap
- $90.26M
- P/E (TTM)
- 2.12
- EPS (TTM)
- $8.01
- Shares outstanding
- 5.31M
Price and trading
- Previous close
- 16.93
- Open
- 16.96
- Day range
- 16.82 – 17.04
- 52-week range
- 3.67 – 17.57
- 52-week change
- +277.90%
- Beta
- —
- Volume
- 7.87K
- Average volume
- 21.33K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 5, 2026
Additional statistics
- Market Cap
- 90.26M
- Pe
- 2.12
- Forward Pe
- -3.15
- Eps
- 8.01
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 17.57
- Week52 Low
- 3.67
- Avg Volume
- 21,326.00
- Shares Outstanding
- 5.31M
- Ma50
- 16.76
- Ma200
- 12.07
- Earnings Date
- Nov 5, 2026
- Pct From52w High
- -3.32%
- Pct From52w Low
- 362.94%